SING GEORGE L — SEC insider filings
SEC reporting owner CIK 1225471. 25 insider filings on record with FilingPulse; latest filed 2026-11-18.
Transaction summary — filings shown
Covers all 25 filings on record, filed 2020-08-24 to 2026-11-18. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 97 legs across 15 filings — 165,284 shares, $111,461,042 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 49.
- Largest priced transaction: sale of 7,073 shares @ $965.38 ($6,828,133) in REGENERON PHARMACEUTICALS, INC., filed 2026-11-04.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| REGENERON PHARMACEUTICALS, INC. (REGN) | Director | 25 | — | 97 legs · 165,284 sh · $111,461,042 | 49 |
Insider filings — SING GEORGE L
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-11-18 | 4 | REGENERON PHARMACEUTICALS, INC. (REGN) | Sale (S): 1,000 @ $960.26 · Sale (S): 176 @ $956.96 · Sale (S): 359 @ $957.49 · Sale (S): 465 @ $958.11 | EDGAR |
| 2026-11-04 | 4 | REGENERON PHARMACEUTICALS, INC. (REGN) | Option exercise (M): 7,830 @ $376.69 · Option exercise (M): 7,439 @ $380.95 · Sale (S): 1,224 @ $960.57 · Sale (S): 540 @ $961.85 · Sale (S): 2,522 @ $962.61 · Sale (S): 4,338 @ $963.47 · +7 more | EDGAR |
| 2026-01-06 | 4 | REGENERON PHARMACEUTICALS, INC. (REGN) | Grant/award (A): 155 @ $0 · Grant/award (A): 1,962 (derivative) @ $0 | EDGAR |
| 2025-12-31 | 4 | REGENERON PHARMACEUTICALS, INC. (REGN) | Option exercise (M): 9,212 @ $520.01 · Tax withholding (F): 6,188 @ $774.03 · Option exercise (M): 9,212 (derivative) @ $0 | EDGAR |
| 2025-01-03 | 4 | REGENERON PHARMACEUTICALS, INC. (REGN) | Option exercise (M): 3,338 @ $413.33 · Tax withholding (F): 1,948 @ $708.19 · Grant/award (A): 166 @ $0 · Option exercise (M): 3,338 (derivative) @ $0 · Grant/award (A): 1,958 (derivative) @ $0 | EDGAR |
| 2024-09-05 | 4 | REGENERON PHARMACEUTICALS, INC. (REGN) | Gift (G): 1,200 @ $0 | EDGAR |
| 2024-05-06 | 4 | REGENERON PHARMACEUTICALS, INC. (REGN) | Option exercise (M): 2,000 @ $413.33 · Tax withholding (F): 877 @ $942.53 · Option exercise (M): 2,000 (derivative) @ $0 | EDGAR |
| 2024-02-28 | 4 | REGENERON PHARMACEUTICALS, INC. (REGN) | Option exercise (M): 500 @ $413.33 · Sale (S): 500 @ $990 · Option exercise (M): 500 @ $413.33 · Sale (S): 500 @ $995 · Option exercise (M): 1,000 (derivative) @ $0 | EDGAR |
| 2024-02-26 | 4 | REGENERON PHARMACEUTICALS, INC. (REGN) | Option exercise (M): 1,000 @ $413.33 · Sale (S): 1,000 @ $970 · Option exercise (M): 1,000 @ $413.33 · Sale (S): 1,000 @ $965 · Option exercise (M): 1,000 @ $413.33 · Sale (S): 1,000 @ $960 · +4 more | EDGAR |
| 2024-02-12 | 4 | REGENERON PHARMACEUTICALS, INC. (REGN) | Option exercise (M): 500 @ $413.33 · Sale (S): 500 @ $945 · Option exercise (M): 500 @ $413.33 · Sale (S): 500 @ $955 · Option exercise (M): 500 (derivative) @ $0 · Option exercise (M): 500 (derivative) @ $0 | EDGAR |
| 2024-01-04 | 4 | REGENERON PHARMACEUTICALS, INC. (REGN) | Grant/award (A): 135 @ $0 · Grant/award (A): 1,607 (derivative) @ $0 | EDGAR |
| 2023-01-05 | 4 | REGENERON PHARMACEUTICALS, INC. (REGN) | Grant/award (A): 165 @ $0 · Grant/award (A): 1,929 (derivative) @ $0 | EDGAR |
| 2022-03-01 | 4 | REGENERON PHARMACEUTICALS, INC. (REGN) | Sale (S): 2,000 @ $621 · Sale (S): 1,000 @ $614 · Sale (S): 1,000 @ $617 | EDGAR |
| 2022-01-05 | 4 | REGENERON PHARMACEUTICALS, INC. (REGN) | Grant/award (A): 191 @ $0 · Grant/award (A): 2,707 (derivative) @ $0 | EDGAR |
| 2021-11-23 | 4 | REGENERON PHARMACEUTICALS, INC. (REGN) | Sale (S): 1,000 @ $655 · Sale (S): 1,000 @ $655 · Sale (S): 1,000 @ $660 | EDGAR |
| 2021-11-18 | 4 | REGENERON PHARMACEUTICALS, INC. (REGN) | Sale (S): 2,000 @ $650 · Sale (S): 2,000 @ $658.79 · Sale (S): 2,000 @ $660 · Sale (S): 4,000 @ $650 · Sale (S): 750 @ $650 | EDGAR |
| 2021-08-30 | 4 | REGENERON PHARMACEUTICALS, INC. (REGN) | Sale (S): 500 @ $670 · Sale (S): 500 @ $675 · Sale (S): 150 @ $672 · Sale (S): 250 @ $670 · Sale (S): 300 @ $672 | EDGAR |
| 2021-08-17 | 4 | REGENERON PHARMACEUTICALS, INC. (REGN) | Sale (S): 705 @ $630 · Sale (S): 1,000 @ $627.50 | EDGAR |
| 2021-08-13 | 4 | REGENERON PHARMACEUTICALS, INC. (REGN) | Sale (S): 1,000 @ $620 · Sale (S): 1,000 @ $621 · Sale (S): 1,000 @ $611 · Sale (S): 500 @ $620 · Sale (S): 300 @ $620 | EDGAR |
| 2021-08-10 | 4 | REGENERON PHARMACEUTICALS, INC. (REGN) | Sale (S): 3,000 @ $611.43 · Sale (S): 1,000 @ $611.23 · Sale (S): 600 @ $615 · Sale (S): 1,000 @ $614 · Sale (S): 1,000 @ $613.01 · Sale (S): 350 @ $612.42 | EDGAR |
| 2021-01-05 | 4 | REGENERON PHARMACEUTICALS, INC. (REGN) | Grant/award (A): 248 @ $0 · Grant/award (A): 3,613 (derivative) @ $0 | EDGAR |
| 2020-08-31 | 4 | REGENERON PHARMACEUTICALS, INC. (REGN) | Sale (S): 3,600 @ $610.45 · Sale (S): 1,400 @ $611.38 · Sale (S): 2,000 @ $612.27 · Sale (S): 1,100 @ $613.54 · Sale (S): 1,900 @ $614.51 | EDGAR |
| 2020-08-27 | 4 | REGENERON PHARMACEUTICALS, INC. (REGN) | Option exercise (M): 12,750 @ $273.67 · Sale (S): 1,400 @ $600.36 · Sale (S): 300 @ $601.75 · Sale (S): 400 @ $602.68 · Sale (S): 3,000 @ $603.53 · Sale (S): 3,705 @ $604.43 · +12 more | EDGAR |
| 2020-08-24 | 4 | REGENERON PHARMACEUTICALS, INC. (REGN) | Sale (S): 3,783 @ $615.51 · Sale (S): 1,742 @ $616.25 · Sale (S): 3,454 @ $617.64 · Sale (S): 1,318 @ $618.49 · Sale (S): 703 @ $619.29 · Option exercise (M): 10,000 @ $57.11 · +24 more | EDGAR |
| 2020-08-24 | 4 | REGENERON PHARMACEUTICALS, INC. (REGN) | Option exercise (M): 10,000 (derivative) @ $0 · Option exercise (M): 5,000 (derivative) @ $0 · Option exercise (M): 4,963 (derivative) @ $0 · Option exercise (M): 10,037 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2020-08-18 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1225471 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs